Guilherme Rabinowits

5PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.

Omid Hamid, Karl D Lewis, Amy Weise

|Feb 06, 2024
Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis.

Talya Salz, Susan Chimonas, Sankeerth Jinna

|Nov 23, 2023
Head and Neck Squamous Cell Carcinoma of Unknown Primary: A Diagnostic Work-Up.

Meenakkshy Manoharan, Noah S Kalman, Guilherme Rabinowits

|Jul 24, 2021
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53.

Mansoor N Saleh, Manish R Patel, Todd M Bauer

|Feb 16, 2018
Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Guilherme Rabinowits, Cecilia Lezcano, Paul J Catalano

Pageof 1